Summary of Study ST001654
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001060. The data can be accessed directly via it's Project DOI: 10.21228/M8PH55 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST001654 |
Study Title | Metabolic profiling of plasma collected from Peromyscus leucopus and Mus musculus following LPS treatment |
Study Type | Untargeted Metabolomic profiling |
Study Summary | Small molecule metabolites were extracted from plasma from Peromyscus leucopus and Mus musculus BALB/c and analyzed by liquid chromatography couple with mass spectrometry (LC-MS). XCMS software was used for peak picking, grouping and retention time correction from LC-MS data and generated a molecular feature spreadsheet. Pathway way enrichment analysis was carried out using Mummichog pathway analysis software using data from feature table. |
Institute | Colorado State University |
Department | Microbiology, Immunology and Pathology |
Laboratory | Belisle Lab |
Last Name | Nurul |
First Name | Islam |
Address | 3185 Rampart Road, Fort Collins, CO 80521 |
nurul.islam@colostate.edu | |
Phone | 970 492 4249 |
Submit Date | 2021-01-13 |
Num Groups | 4 |
Total Subjects | 40 |
Num Males | 20 |
Num Females | 20 |
Raw Data Available | Yes |
Raw Data File Type(s) | mzML |
Analysis Type Detail | LC-MS |
Release Date | 2021-03-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001060 |
Project DOI: | doi: 10.21228/M8PH55 |
Project Title: | Investigation of infection-tolerance phenomenon in mammalian reservoir of Lyme disease, Peromyscus leucopus |
Project Type: | Comparative study of Peromyscus leucopus and Mus musculus, BALB/c, metabolic response to endotoxin treatment |
Project Summary: | Infection-tolerance mechanism were investigated in a natural reservoir of Lyme disease, Peromyscus leucopus, white-footed deermice following exposure of a single dose of lipopolysaccharide endotoxin. The multiparametric responses of this treatment were compared to widely used mouse model, Mus musculus BALB/c. Following LPS and saline treatment, samples from blood, spleen and liver tissues were collected postmortem from both animals and subjected to RNA-seq, untargeted metabolomics and specific RT-qPCR. |
Institute: | Colorado State University |
Department: | Microbiology, Immunology and Pathology |
Laboratory: | Belisle Lab |
Last Name: | Nurul |
First Name: | Islam |
Address: | 3185 Rampart Road, Fort Collins, CO 80521 |
Email: | nurul.islam@colostate.edu |
Phone: | 970 492 4249 |
Funding Source: | NIH and the Office of the Assistant Secretary of Defense for Health Affairs through the Tick Borne Disease Research Program |
Project Comments: | N/A |
Publications: | N/A |
Contributors: | Gabriela Balderrama Gutierrez, Ana Milovic, Vanessa J. Cook, M. Nurul Islam, Youwen Zhang, Hippokratis Kiaris, John T. Belisle, Ali Mortazavi and Alan G. Barbour. |
Subject:
Subject ID: | SU001731 |
Subject Type: | Mammal |
Subject Species: | Mus musculus;Peromyscus leucopus |
Taxonomy ID: | 10090;10041 |
Gender: | Male and female |
Factors:
Subject type: Mammal; Subject species: Mus musculus;Peromyscus leucopus (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample Type |
---|---|---|
SA151775 | Peromyscus_22275_Control_Plasma | control (saline) |
SA151776 | Mus_F101_Control_Plasma | control (saline) |
SA151777 | Mus_106_Control_Plasma | control (saline) |
SA151778 | Mus_120_Control_Plasma | control (saline) |
SA151779 | Mus_116_Control_Plasma | control (saline) |
SA151780 | Mus_102_Control_Plasma | control (saline) |
SA151781 | Mus_M404_Control_Plasma | control (saline) |
SA151782 | Mus_115_Control_Plasma | control (saline) |
SA151783 | Mus_F302_Control_Plasma | control (saline) |
SA151784 | Peromyscus_22335_Control_Plasma | control (saline) |
SA151785 | Peromyscus_22341_Control_Plasma | control (saline) |
SA151786 | Peromyscus_22321_Control_Plasma | control (saline) |
SA151787 | Peromyscus_22315_Control_Plasma | control (saline) |
SA151788 | Peromyscus_22277_Control_Plasma | control (saline) |
SA151789 | Peromyscus_22282_Control_Plasma | control (saline) |
SA151790 | Peromyscus_22279_Control_Plasma | control (saline) |
SA151791 | Mus_109_LPS_Plasma | lipopolysaccharide |
SA151792 | Mus_107_LPS_Plasma | lipopolysaccharide |
SA151793 | Mus_M205_LPS_Plasma | lipopolysaccharide |
SA151794 | Mus_108_LPS_Plasma | lipopolysaccharide |
SA151795 | Mus_M407_LPS_Plasma | lipopolysaccharide |
SA151796 | Mus_F303_LPS_Plasma | lipopolysaccharide |
SA151797 | Peromyscus_22258_LPS_Plasma | lipopolysaccharide |
SA151798 | Mus_M406_LPS_Plasma | lipopolysaccharide |
SA151799 | Mus_118_LPS_Plasma | lipopolysaccharide |
SA151800 | Peromyscus_22319_LPS_Plasma | lipopolysaccharide |
SA151801 | Peromyscus_22284_LPS_Plasma | lipopolysaccharide |
SA151802 | Peromyscus_22316_LPS_Plasma | lipopolysaccharide |
SA151803 | Peromyscus_22325_LPS_Plasma | lipopolysaccharide |
SA151804 | Peromyscus_22327_LPS_Plasma | lipopolysaccharide |
SA151805 | Peromyscus_22339_LPS_Plasma | lipopolysaccharide |
SA151806 | Peromyscus_22292_LPS_Plasma | lipopolysaccharide |
SA151807 | Peromyscus_22289_LPS_Plasma | lipopolysaccharide |
SA151808 | Mus_104_LPS_Plasma | lipopolysaccharide |
SA151809 | Mus_105_LPS_Plasma | lipopolysaccharide |
SA151810 | Mus_103_LPS_Plasma | lipopolysaccharide |
SA151811 | Mus_101_LPS_Plasma | lipopolysaccharide |
SA151812 | Peromyscus_22278_LPS_Plasma | lipopolysaccharide |
SA151813 | Peromyscus_22281_LPS_Plasma | lipopolysaccharide |
SA151814 | Peromyscus_22332_LPS_Plasma | lipopolysaccharide |
SA151768 | Pooled_QC03 | Pooled quality control sample |
SA151769 | Pooled_QC01 | Pooled quality control sample |
SA151770 | Pooled_QC04 | Pooled quality control sample |
SA151771 | Pooled_QC02 | Pooled quality control sample |
SA151772 | Pooled_QC05 | Pooled quality control sample |
SA151773 | Pooled_QC07 | Pooled quality control sample |
SA151774 | Pooled_QC06 | Pooled quality control sample |
Showing results 1 to 47 of 47 |
Collection:
Collection ID: | CO001724 |
Collection Summary: | At 4.0 hr after LPS injection the animals were euthanized. After opening the chest, exsanguination was performed by cardiac puncture and blood was transferred to a heparin sulfate coated tubes (Becton-Dickinson Microtainer). Anticoagulated blood was centrifuged to pellet blood cells for 3 min at 4600 x g at 4° C. Plasma and blood pellet was kept separately at -80° C until further analysis. |
Sample Type: | Blood (plasma) |
Storage Conditions: | -80℃ |
Treatment:
Treatment ID: | TR001744 |
Treatment Summary: | Animals were anesthetized with isoflurane and injected i.p. with a single dose of E. coli O111:B4 LPS at a concentration of 10 µg/gm body weight in a 50 µl volume as described above. The control group was anesthetized and then injected with the 0.9% saline alone. The experiment started at 0800 h with 10 min intervals between animals and with alteration of LPS and control injections. At 4.0 hr after their injection the animals were euthanized. After opening the chest, exsanguination was performed by cardiac puncture and blood was transferred to a heparin sulfate coated tubes (Becton-Dickinson Microtainer). Anticoagulated blood was centrifuged to pellet blood cells for 3 min at 4600 x g at 4° C. Plasma and blood pellet was kept separately at -80° C until further analysis. |
Treatment Compound: | E. coli O111:B4 LPS |
Treatment Route: | i.p. |
Treatment Dose: | 10 µg/gm body weight |
Treatment Dosevolume: | 50 µl volume |
Treatment Vehicle: | sterile, endotoxin-free 0.9% saline |
Animal Anesthesia: | isoflurane |
Sample Preparation:
Sampleprep ID: | SP001737 |
Sampleprep Summary: | Metabolites were extracted from aliquots of 40 µL of plasma with 75% LC-MS grade methanol, supernatants were dried, resuspended in 50% methanol, 10 µL samples were subjected to liquid chromatography and mass spectrometry. Pooled quality control sample was prepared by mixing small aliquot (10 µL) of each plasma sample in the study. |
Combined analysis:
Analysis ID | AN002701 |
---|---|
Analysis type | MS |
Chromatography type | Reversed phase |
Chromatography system | Agilent 1260 |
Column | Agilent Poroshell 120 EC-C8 (100 x 2.1mm,2.7um) |
MS Type | ESI |
MS instrument type | QTOF |
MS instrument name | Agilent 6520 QTOF |
Ion Mode | POSITIVE |
Units | peak area |
Chromatography:
Chromatography ID: | CH001993 |
Instrument Name: | Agilent 1260 |
Column Name: | Agilent Poroshell 120 EC-C8 (100 x 2.1mm,2.7um) |
Column Temperature: | 50 |
Flow Gradient: | non-linear gradient |
Flow Rate: | 0.25 mL/min |
Solvent A: | 100% water; 0.1% formic acid |
Solvent B: | 100% acetonitrile; 0.1% formic acid |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS002499 |
Analysis ID: | AN002701 |
Instrument Name: | Agilent 6520 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | An aliquot of sample was injected into LC-MS to acquire data in positive mode. Data acquisition and analysis were achieved using MassHunter software. |
Ion Mode: | POSITIVE |
Capillary Voltage: | 4000V |
Dry Gas Temp: | 300 degree C |
Fragment Voltage: | 120V |
Gas Pressure: | 45 |